ERN1 and renal cell carcinoma: The same study reported that inhibitors of PERK (GSK2656157) or IRE1α (4μ8C), or, alternatively, genetic deletion of PERK or IRE1α, significantly prevented overexpression of these inflammatory cytokines in 786-O RCC cells [47].